Skip to content

Clinical trials

Phase 3 Carcinoma, Renal Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 3 Country / region: Belgium Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20051
20081
20102
20111
20121
20131
20141
20163
20172
20193
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting4
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
European Organisation for Research and Treatment of Cancer - EORTC3
AVEO Pharmaceuticals, Inc.2
Bayer2
Exelixis2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Pfizer2
Agenus Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell25
Kidney Neoplasms8
Neoplasms6
Carcinoma2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Disease Progression1
Kidney Diseases1
Neoplasm Metastasis1
Ovarian Neoplasms1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.